Barbra Streisand asked Melissa McCarthy about the weight loss drug Ozempic publicly on Instagram, prompting backlash from followers; Streisand later explained she meant to compliment McCarthy and forgot about the public nature of the platform. McCarthy, 53, has not responded. Ozempic, originally for diabetes, suppresses appetite and prolongs stomach digestion, aiding in weight loss, although it's banned for obesity treatment in the UK due to global shortages caused by high demand. Some Hollywood stars have reportedly used Ozempic for weight loss, but few have openly admitted to it.
Barbra Streisand faced criticism for asking Melissa McCarthy on Instagram about her use of Ozempic for weight loss, a comment she later deleted but was preserved by @CommentsByCelebs. McCarthy had shared pictures from a gala with choreographer Adam Shankman, wearing pastel outfits. Mention of body image and the off-label use of Ozempic for weight loss stirred social media reactions. Celebrities like Amy Schumer and Sharon Osbourne have discussed using the diabetes drug for weight loss despite it not being FDA-approved for that purpose.
Celebrities like Tori Spelling, Ree Drummond, and Tracy Morgan have shared their experiences using antidiabetic drugs such as Ozempic and Mounjaro for weight loss. Tori Spelling turned to Mounjaro after trying Ozempic post-pregnancy. She mentioned feeling unashamed about it in today's context. Tracy Morgan and Ree Drummond also spoke about their weight loss journeys, with Morgan citing appetite suppression as a benefit of using Ozempic.
Kelly Osbourne refutes claims of using Ozempic for weight loss, instead crediting cutting out sugar and carbs post-gestational diabetes for losing 85 pounds. Sharon Osbourne, her mother, revealed losing 40 pounds on Ozempic with side effects like nausea, emphasizing no regrets about the choice.
Jon Gosselin, from Jon & Kate Plus 8, lost 32 pounds in two months by using Ozempic (semaglutide) and celebrated his results, feeling 'amazing.' He regretted not starting the medication sooner, attributing his weight gain to emotional stresses, career changes, and late-night eating habits. Ozempic helped him control his appetite and cut down on alcohol, avoiding invasive surgeries for body contouring. His weight loss journey reflects his focus on healthier habits post-divorce and custody battles with ex-wife Kate Gosselin.
Food Network star Sandra Lee experienced severe side effects after trying weight loss injections, losing 10lbs but feeling extremely sick. Celebrities like Kelly Osbourne, Oprah Winfrey, Amy Schumer, and Boy George have praised Ozempic for weight loss, with some cautioning about unpleasant side effects. Sandra Lee, known for her cooking, tried a strict cleanse after gaining weight in 2020. She emphasizes healthy, quick meals for families on her new show and admires fashion icon Bob Mackie's influence on the industry.
Why the long face? Ozempic. Amid the weight loss treatments skyrocketing popularity, surgeons believe that Hollywood is experiencing a spike in the side effect known as Ozempic Face. Several doctors claimed to the Daily Mail that celebs from John Goodman to Sharon Osborne are among those hit hardest by the alleged condition. For the uninitiated, some side effects of taking Ozempic include sunken eyes, gaunt cheeks and saggy skin, often making the user appear older and more deflated . Ozempic face is essentially the same characteristics that we see when patients have rapid or regular weight loss, Dr.
Reality TV star Mama June Shannon, known for her struggles with weight, shared her journey using injectable medications for weight loss after a gastric sleeve surgery in 2015. She went from 550 pounds to 195, maintaining a weight of 130 to 150 pounds until stress caused her to gain back 120 to 130 pounds. Shannon is now trying semaglutide under brand names like Ozempic and Wegovy, expressing nerves about the treatment. Other celebrities like Tracy Morgan and Sharon Osbourne have also discussed using weight loss drugs, with semaglutide products approved for weight loss despite being initially intended for Type 2 diabetes treatment.
The weight loss drug Wegovy has helped a 58-year-old Manhattan resident lose 30 pounds, leading to a shift in perspective towards obesity as a disease requiring medical intervention. Recent injected drugs like Wegovy and Ozempic are transforming the U.S. health and fitness industries, with concerns raised about non-experts dispensing prescription medications. At least 3 million prescriptions for GLP-1 agonists, the class of medications including these drugs, are issued monthly in the U.S.
TikTok, with over 170 million users in the US, will ban before-and-after photos for weight-loss drugs like Ozempic and Mounjaro in May. The app aims to restrict harmful weight management content and not allow minors to view such posts. Influencers face limitations on promoting rapid weight loss methods. Those affected plan to shift content to platforms like Instagram and Clapper. The popularity of these drugs, like Mounjaro and Ozempic, has led to significant sales for companies including Eli Lilly and Novo Nordisk.
Weight loss drugs continue to gain in popularity, but not everyone who wants them can afford these medications, leaving some people hunting for more cost-effective alternatives. While natural options may seem promising, their effectiveness can be unpredictable. Berberine , for example, has been labeled natures Ozempic, though it may help more with managing blood sugar levels than aiding in actual weight loss. Meanwhile, psyllium husk an inexpensive fiber supplement is sought-after for its ability to temporarily suppress appetite by promoting a sense of fullness, but its important to note that fiber alone does not directly cause weight loss. More recently, theres been a viral trend involving the consumption of oatzempic, a drink crafted from oats, water and lime juice blended together.
Popular diabetes medications like Ozempic are being used for weight loss but have unexpected side effects like emotional dulling, reduced libido, and decreased addictions. Researchers attribute these effects to the drugs' impact on dopamine, a key brain chemical responsible for various human behaviors.
BAGSVAERD, Denmark Lars Fruergaard Jorgensen has a problem: Too many people want what hes selling. Jorgensen is CEO of Novo Nordisk, a Danish drugmaker. Even if the company isnt quite a household name, the TV jingle for its bestselling drug Oh-oh-ohhh-Ozempic! might ring in your ears. Across the United States, Novo Nordisks diabetes and weight-loss drugs, Ozempic and Wegovy, have soared to celebrity status and helped make the company Europes most valuable public firm. It cant make enough of the drugs.
Semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain. It can be administered by subcutaneous injection or taken orally. It is sold under the brand names Ozempic and Rybelsus for diabetes, and under the brand name Wegovy for weight loss.Semaglutide is a glucagon-like peptide-1 receptor agonist. The most common side effects include nausea, vomiting, diarrhea, abdominal pain, and constipation.It was approved for medical use in the US in 2017. In 2021, it was the 90th most commonly prescribed medication in the United States, with more than 8 million prescriptions.
The Federal Trade Commission is challenging patents on 20 brand name drugs, including the weight-loss injection Ozempic, alleging that certain patents filed by companies like Novo Nordisk and GlaxoSmithKline are inaccurate or misleading. By challenging these patents, the Biden administration aims to address industry practices that drive up pharmaceutical prices. Brand-name drugmakers use patents to protect their medicines and prevent generic competition, leading to inflated prescription drug costs for consumers. The FTC's recent actions follow a previous challenge to over 100 patents held by companies such as Abbvie and AstraZeneca.
European Medicines Agency regulatory committee concluded that popular drugs like Ozempic and Wegovy do not pose a higher risk of suicidal thoughts or actions. The review was triggered by anecdotal reports last July, with the U.S. FDA also stating no evidence of a link. A U.S. study found lower risk of suicidal thoughts with semaglutide, the drug in question. Monitoring will continue, and patients are advised to report any issues to healthcare providers.
:max_bytes(150000):strip_icc()/Melissa-McCarthy-Barbra-Streisand-043024-bd2fb81772c6454fbd29ce0280ce66e4.jpg)
NY Post
NY Post
Yahoo! News
The Huffington Post
https://www.facebook.com/entertainmentweekly
Eve Buckland
E! News
Sky News
PANORA
PANORA
PANORA
PANORA
PANORA
PANORA
PANORA
PANORA
PANORA
PANORA
PANORA
PANORA
Wikipedia
PANORA
PANORA